mole 4d4D-175 combines the customized and evolved intravitreal vector, R100, and a codon-optimized transgene encoding a hhly functional shortened form of human complement factor H (sCFH).The genetic medicine candidate is desned to4D Molecular Therapeutics desns, develops and mercializes transformative gene therapeutic products for serious unmet medical conditions.